Citation Tools

Download PDFPDF

617 Trastuzumab and pertuzumab combination therapy activates complement-dependent cytotoxicity and phagocytosis against HER2+ breast cancer
Free

Download to a citation manager

Cite this article as:
Tsao L, Hartman Z
617 Trastuzumab and pertuzumab combination therapy activates complement-dependent cytotoxicity and phagocytosis against HER2+ breast cancer